Denys D - Search Results

1

Reduced striatal dopamine D2/3 receptor availability in Body Dysmorphic Disorder.

Vulink NC, Planting RS, Figee M, Booij J, Denys D. Vulink NC, et al. Among authors: denys d. Eur Neuropsychopharmacol. 2016 Feb;26(2):350-356. doi: 10.1016/j.euroneuro.2015.11.018. Epub 2015 Nov 30. Eur Neuropsychopharmacol. 2016. PMID: 26711686

2

Low level of dopaminergic D2 receptor binding in obsessive-compulsive disorder.

Denys D, van der Wee N, Janssen J, De Geus F, Westenberg HG. Denys D, et al. Biol Psychiatry. 2004 May 15;55(10):1041-5. doi: 10.1016/j.biopsych.2004.01.023. Biol Psychiatry. 2004. PMID: 15121489

3

Association between the dopamine D2 receptor TaqI A2 allele and low activity COMT allele with obsessive-compulsive disorder in males.

Denys D, Van Nieuwerburgh F, Deforce D, Westenberg H. Denys D, et al. Eur Neuropsychopharmacol. 2006 Aug;16(6):446-50. doi: 10.1016/j.euroneuro.2005.12.001. Epub 2006 Jan 19. Eur Neuropsychopharmacol. 2006. PMID: 16427255 Free article.

4

Spatial working memory in obsessive-compulsive disorder improves with clinical response: A functional MRI study.

van der Wee NJ, Ramsey NF, van Megen HJ, Denys D, Westenberg HG, Kahn RS. van der Wee NJ, et al. Among authors: denys d. Eur Neuropsychopharmacol. 2007 Jan;17(1):16-23. doi: 10.1016/j.euroneuro.2006.04.012. Epub 2006 Jun 21. Eur Neuropsychopharmacol. 2007. PMID: 16797166 Clinical Trial.

5

New pharmacotherapeutic approaches to obsessive-compulsive disorder.

Figee M, Denys D. Figee M, et al. Among authors: denys d. CNS Spectr. 2009 Feb;14(2 Suppl 3):13-23. doi: 10.1017/s1092852900027255. CNS Spectr. 2009. PMID: 19238126

6

Lipopolysaccharide-induced cytokine production in obsessive-compulsive disorder and generalized social anxiety disorder.

Fluitman S, Denys D, Vulink N, Schutters S, Heijnen C, Westenberg H. Fluitman S, et al. Among authors: denys d. Psychiatry Res. 2010 Jul 30;178(2):313-6. doi: 10.1016/j.psychres.2009.05.008. Epub 2010 May 7. Psychiatry Res. 2010. PMID: 20452055

7

Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive-compulsive disorder.

Denys D, Mantione M, Figee M, van den Munckhof P, Koerselman F, Westenberg H, Bosch A, Schuurman R. Denys D, et al. Arch Gen Psychiatry. 2010 Oct;67(10):1061-8. doi: 10.1001/archgenpsychiatry.2010.122. Arch Gen Psychiatry. 2010. PMID: 20921122 Clinical Trial.

8

Dysfunctional reward circuitry in obsessive-compulsive disorder.

Figee M, Vink M, de Geus F, Vulink N, Veltman DJ, Westenberg H, Denys D. Figee M, et al. Among authors: denys d. Biol Psychiatry. 2011 May 1;69(9):867-74. doi: 10.1016/j.biopsych.2010.12.003. Epub 2011 Jan 26. Biol Psychiatry. 2011. PMID: 21272861

9

Review of atypical antipsychotics in anxiety.

Vulink NC, Figee M, Denys D. Vulink NC, et al. Among authors: denys d. Eur Neuropsychopharmacol. 2011 Jun;21(6):429-49. doi: 10.1016/j.euroneuro.2010.12.007. Epub 2011 Feb 22. Eur Neuropsychopharmacol. 2011. PMID: 21345655 Review.

10

Current status of deep brain stimulation for obsessive-compulsive disorder: a clinical review of different targets.

de Koning PP, Figee M, van den Munckhof P, Schuurman PR, Denys D. de Koning PP, et al. Among authors: denys d. Curr Psychiatry Rep. 2011 Aug;13(4):274-82. doi: 10.1007/s11920-011-0200-8. Curr Psychiatry Rep. 2011. PMID: 21505875 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

407 results

Search Page

Filters